Diabetes Board decisions

The Board denied earlier effective dates for the veteran's service-connected conditions, except for diabetes mellitus type II which was granted an effective date of February 25, 2019.

The Board granted service connection for left knee disability, migraine headaches, irritable bowel syndrome (IBS), diabetes mellitus, type II, and tinnitus. The claims for depressive disorder and generalized anxiety disorder were remanded.

The Board granted service connection for diabetes mellitus type II, right and left lower extremity diabetic peripheral neuropathy, and coronary artery disease based on herbicide exposure in Thailand.

The Board denied service connection for chronic obstructive pulmonary disease, thyroid cancer, and diabetes mellitus type II as the evidence did not support a causal relationship between these conditions and the Veteran's military service or any toxic exposures.

The Board remands the claims for service connection for diabetes mellitus, type II, and bilateral knee disorders as further development is needed to address pre-decisional duty to assist errors.

The Board remands the claims for service connection due to insufficient evidence regarding the Veteran's duty status during his motor vehicle crash.

The Board remands the claims for service connection for coronary artery disease, diabetes mellitus, diverticulitis, obstructive sleep apnea, and benign prostate hypertrophy to ensure adequate medical opinions are obtained.

The Board denied the appellant's claims for service connection for the Veteran's cause of death, increased disability ratings for lumbosacral strain and right inguinal surgical scar.

The Board remands the claim for a new VA examination to address the etiology of the Veteran's diabetes mellitus, type II, including its potential connection to exposure at Camp Lejeune and service-connected disabilities.

The Board granted service connection for diabetes, finding that the Veteran's diabetes was incurred in service and due to his in-service exposure to burn pits.

The Board found that new and relevant evidence had not been presented to warrant readjudication of the claim for service connection for diabetes mellitus, type II (DM).

The Board remands the claims for service connection for various conditions due to an inadequate VA medical opinion.

The Board granted service connection for diabetes mellitus, type II from August 10, 2022, and denied a rating greater than 70 percent for post-traumatic stress disorder (PTSD) as well as entitlement to individual unemployability.

The appeal concerning the issues of heart condition and diabetes was dismissed due to an improper concurrent election.

The Board remands the claims for service connection for Parkinson's disease and diabetes mellitus, type II, to obtain an addendum opinion addressing the Veteran's toxic exposure risk activities.

The Board denied increased evaluations for diabetic peripheral neuropathy, diabetes mellitus, type II, and a separate compensable evaluation for dry eye.

The Board denied the appeal to restore service connection for diabetes mellitus type II, finding clear and unmistakable error in the original grant of service connection due to a lack of qualifying service near the DMZ.

The Board denied service connection for type II diabetes mellitus, erectile dysfunction, hypertension, and bleeding of the eyes as there is no evidence that these conditions are related to the Veteran's military service.

The Board granted an 80 percent disability rating for seizure disorder, a 30 percent rating for left eye atrophy and blindness, and a TDIU due to the seizure disorder. The discontinuation of the 100 percent disability rating for Rosai-Dorfman disease was upheld.

The Board remands the claims for service connection for coronary artery disease and type II diabetes due to inadequate medical opinions regarding toxic exposures, including jet fuel and cleaning solvents.